Utah Medical Products (NASDAQ:UTMD) Stock Price Crosses Above 200-Day Moving Average – What’s Next?

Utah Medical Products, Inc. (NASDAQ:UTMD) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $61.36 and traded as high as $64.27. Utah Medical Products shares last traded at $64.05, with a volume of 11,556 shares trading hands.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded shares of Utah Medical Products from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, February 25th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Utah Medical Products currently has a consensus rating of “Hold”.

Utah Medical Products Trading Up 0.4%

The company’s fifty day moving average is $65.21 and its 200-day moving average is $61.36. The firm has a market capitalization of $203.68 million, a P/E ratio of 18.95 and a beta of 0.37.

Utah Medical Products (NASDAQ:UTMD) last posted its quarterly earnings data on Thursday, April 23rd. The medical instruments supplier reported $0.82 earnings per share (EPS) for the quarter. The business had revenue of $8.72 million during the quarter. Utah Medical Products had a net margin of 28.90% and a return on equity of 9.17%.

Utah Medical Products Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 3rd. Investors of record on Wednesday, June 17th will be issued a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, June 17th. Utah Medical Products’s dividend payout ratio is currently 36.69%.

Institutional Trading of Utah Medical Products

Several large investors have recently modified their holdings of UTMD. Segall Bryant & Hamill LLC acquired a new position in Utah Medical Products during the 3rd quarter valued at $726,000. Brandes Investment Partners LP raised its stake in Utah Medical Products by 4.0% during the 4th quarter. Brandes Investment Partners LP now owns 351,322 shares of the medical instruments supplier’s stock valued at $19,660,000 after purchasing an additional 13,392 shares during the last quarter. Everett Harris & Co. CA raised its stake in Utah Medical Products by 24.1% during the 4th quarter. Everett Harris & Co. CA now owns 21,344 shares of the medical instruments supplier’s stock valued at $1,194,000 after purchasing an additional 4,151 shares during the last quarter. Minerva Advisors LLC raised its stake in Utah Medical Products by 0.6% during the 4th quarter. Minerva Advisors LLC now owns 93,615 shares of the medical instruments supplier’s stock valued at $5,239,000 after purchasing an additional 557 shares during the last quarter. Finally, LSV Asset Management raised its stake in shares of Utah Medical Products by 3.9% in the 4th quarter. LSV Asset Management now owns 13,474 shares of the medical instruments supplier’s stock valued at $754,000 after buying an additional 500 shares in the last quarter. 69.60% of the stock is owned by institutional investors.

About Utah Medical Products

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single?use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non?invasive monitoring products used in acute and long?term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end?tidal carbon dioxide (CO?).